Unique inflammatory profile is associated with higher SARS-CoV-2 acute respiratory distress syndrome (ARDS) mortality
- 1 March 2021
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 320 (3) , R250-R257
Abstract
The COVID19 pandemic has caused more than a million of deaths worldwide, primarily due to complications from COVID19-associated acute respiratory distress syndrome (ARDS). Controversy surrounds the circulating cytokine/chemokine profile of COVID19-associated ARDS, with some groups suggesting that it is similar to patients without COVID19 ARDS and others observing substantial differences. Moreover, although a hyperinflammatory phenotype associates with higher mortality in non-COVID19 ARDS, there is little information on the inflammatory landscape’s association with mortality in patients with COVID19 ARDS. Even though the circulating leukocytes’ transcriptomic signature has been associated with distinct phenotypes and outcomes in critical illness including ARDS, it is unclear whether the mortality-associated inflammatory mediators from patients with COVID19 are transcriptionally regulated in the leukocyte compartment. Here, we conducted a prospective cohort study of 41 mechanically ventilated patients with COVID19 infection using highly calibrated methods to define the levels of plasma cytokines/chemokines and their gene expressions in circulating leukocytes. Plasma IL1RA and IL8 were found positively associated with mortality, whereas RANTES and EGF negatively associated with that outcome. However, the leukocyte gene expression of these proteins had no statistically significant correlation with mortality. These data suggest a unique inflammatory signature associated with severe COVID19.Keywords
All Related Versions
Funding Information
- HHS | NIH | National Heart, Lung, and Blood Institute (HL130704)
- HHS | NIH | National Heart, Lung, and Blood Institute (5R01HL049426)
- HHS | NIH | National Institute of General Medical Sciences (1R01GM124133)
- HHS | NIH | National Institute of General Medical Sciences (GM108538)
This publication has 54 references indexed in Scilit:
- IL1RN Coding Variant Is Associated with Lower Risk of Acute Respiratory Distress Syndrome and Increased Plasma IL-1 Receptor AntagonistAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Innate lymphoid cells — a proposal for uniform nomenclatureNature Reviews Immunology, 2013
- Exudate Macrophages Attenuate Lung Injury by the Release of IL-1 Receptor Antagonist in Gram-negative PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Simultaneous and selective inference: Current successes and future challengesBiometrical Journal, 2010
- Sex-specific association of epidermal growth factor gene polymorphisms with acute respiratory distress syndromeEuropean Respiratory Journal, 2008
- Anakinra (IL‐1R antagonist) lowers pulmonary artery pressure in a neonatal surfactant depleted piglet modelPediatric Pulmonology, 2008
- Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injuryProceedings of the National Academy of Sciences, 2007
- Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenzaProceedings of the National Academy of Sciences, 2007
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987